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Background: Pregnancy handheld records (PHR) are a personally controlled health record 
utilised in the promotion of continuity of care across pregnancy by providing a single resource 
for the recording of pregnancy related health information.  
Aims: To determine the accuracy of the PHR in relation to information on medications and 
adverse drug reactions (ADRs) and to examine the frequency and nature of any identified 
discrepancies. 
Method: A 12 week prospective clinical audit of 300 women admitted to either the antenatal 
or postnatal ward at a tertiary level maternity hospital. A detailed medication history was 
completed for each woman by a pharmacist, with women interviewed about medication use 
prior to and during their pregnancy as well as any ADRs. The medication history and PHR 
were compared to identify discrepancies. 
Results: Medication discrepancies were extremely common, with 254 (84.7%; 95% CI 80.6-
88.8%) women having at least one or more medication related discrepancy involving 686 
(55%; 95% CI 52.2–57.8%) prescription and non-prescription medications. Most common 
reasons for prescription medication discrepancies included the medication details being 
incomplete (44%), missing (29%), or incorrect (17%). ADR and allergy discrepancies were 
also common, identified among 59 (20%; 95% CI 15.5-24.5%) women.   
Conclusions: The PHR is of low accuracy in relation to the recording of medications and 
ADRs.  This warrants further research to examine the impact of these discrepancies on patient 
care and outcomes. The identification of strategies for improving the recording of information 
on medications and ADRs in the PHR are also required.  
Manuscript Text 





The pregnancy handheld record (PHR) was developed to support collaboration and co-
ordination of treatment efforts across the healthcare team.1, 2 During antenatal visits healthcare 
providers complete relevant information in the PHR pertinent to patient care during pregnancy 
and birth, with an aim to increase health professional communication and reduce clinical 
errors.3 
While the PHR format varies across settings, the amount of space and prominence provided to 
recording information on medications and ADRs is less than ideal. This is despite medication 
use during pregnancy being extremely common, with recent studies reporting that eight out of 
ten women use at least one medication during pregnancy.4, 5 Coupled with this is the fact that 
chronic medical conditions are common during pregnancy, with a recent Australian study 
reporting that 39.3% of surveyed pregnant women had at least one medical condition and 
26.5% of them were taking medications for those conditions.5 This is in addition to the 
knowledge that pregnancy not only has a unique effect on decisions relating to medication use, 
largely due to concerns regarding medication safety, but can also influence medication 
pharmacokinetics and therefore alter treatment efficacy or toxicity.6 Further complicating this 
is that evidence regarding medication use in pregnancy is often lacking, contradictory or 
difficult to interpret and apply to clinical practice.7, 8 
While a number of studies have examined the broad benefits of using a PHR, no specific studies 
have assessed the accuracy of a PHR in areas such as information recorded on medication use 
and ADRs. Therefore, the aim of this study was to determine the accuracy of the PHR in 
relation to information on medications and ADRs and examine the frequency and nature of any 
identified discrepancies.  
Method 




Prospective clinical audit of antenatal and postnatal women admitted to Flinders Medical 
Centre (FMC), South Australia, between 1 April and 23 June 2014. Each year, approximately 
3,000 births occur at FMC, a university-affiliated tertiary level teaching hospital, which has a 
14 bed antenatal ward and 18 bed postnatal ward. Ethics approval was obtained from the 
Southern Adelaide Local Health Network Ethics Committee (HREC/14/SAC/48). 
Inclusion/Exclusion Criteria 
As the study was dependant on a detailed medication history interview being undertaken by a 
pharmacist, only women who could be seen during standard clinical pharmacy working hours 
(Monday to Friday – 0845 to 1700) were eligible. Women were not included in the study in 
situations where a language barrier was present and no interpreter was available, or in sensitive 
situations where the treating midwife deemed it inappropriate to enter the woman’s room at 
that point in time.  
Data collection  
In accordance with the routine clinical pharmacy service provided within the hospital, each 
woman underwent a detailed medication history interview with a pharmacist. The medication 
history interview was undertaken using a structured medication history taking instrument 
developed specifically for this study. The instrument consisted of two main parts including 
medications and allergies or ADRs. Women were asked to specify all use of prescription or 
non-prescription medications prior to and during their pregnancy with information recorded 
on: commencement and cessation dates, medication name, strength, dose, form, route, 
administration schedule, and the indication for use. Prescription medications were defined as 
medications only available by prescription from a doctor, while non-prescription medications 
were defined as medications available without a prescription from a community pharmacy or 
alternative location (e.g. supermarket or health food store). Non-prescription medicines 




included the use of complementary medicines, including herbal and dietary supplements. While 
some medications may be available both with and without a prescription (e.g. paracetamol, 
Non-steroidal anti-inflammatory drugs [NSAIDs], folic acid, iron supplements), these were 
classified as non-prescription medicines for the purposes of this study. Initiation of medications  
or allergies or ADRs experienced during the woman’s current hospital admission were not 
included in the study, as these would not have been routinely recorded in the PHR. Women 
were also asked about any allergies or ADRs, with data collected on the medication involved 
(or other trigger), reaction type, reaction date, and whether this has subsequently been 
confirmed through allergy testing. Allergies were defined as non-medication related reactions, 
for example food allergies, whereas ADRs were defined as adverse reactions to medications. 
Demographic information including employment status, age, height, weight, medical 
conditions and ethnicity, obstetric history, and obstetric complications, were collected based 
on data recorded in the medical records.  
For the purpose of identifying discrepancies, the pharmacist completed medication history was 
classified as the ‘gold standard’ and used as a point of comparison with the PHR. Any 
discrepancies that were identified by the pharmacist in the PHR were subsequently recorded. 
Discrepancies identified were categorised as prescription or non-prescription discrepancies and 
categorised into four groups (Table 1). ADRs were categorised using a similar concept, 
however they were only categorised into three different groups (Table 1). All medications were 
categorised according to the World Health Organisation (WHO) Anatomical Therapeutic 
Chemical (ATC) Classification System.  
Sample Size Calculation 
In the absence of previous literature, anecdotal evidence was used to hypothesise a 70% level 
of accuracy of information of medication use recorded in PHR; that is for 7 out of 10 women 




the PHR would correctly identify medication use during pregnancy. To estimate the prevalence 
within 5 percentage points of the true value (65-75%) with 95% confidence, a sample size of 
approximately 300 participants was required.   
Statistical Analysis 
Differences were examined using a Chi-squared test for nominal variables and Chi-squared test 
for trend for ordinal variables. Analyses were undertaken using Statistical Package for Social 
Sciences (SPSS) version 22.0, with a p-value < 0.05 considered statistically significant.  
Results 
A total of 300 women were included in the study, with 29 (10%) being antenatal and 271 (90%) 
postnatal. Mean age and BMI was 30 years (±6 SD) and 28 kg/m2 (±7 SD) respectively. The 
majority of women were of Caucasian ethnicity (n=258: 87%), non-smokers (n=266: 89%), 
and currently employed (n=202: 68%). Pre-existing medical conditions were reported for 149 
(50%) women and included conditions such as asthma (n=72; 24%), anxiety or depression 
(n=65; 22%), thyroid disorder (n=13; 4%), neurological disorder (n=9; 3%), polycystic ovary 
syndrome (n=8; 3%) gastrointestinal disorder (n=4; 1%), Type 1 or Type 2 diabetes (n=4; 1%), 
and hypertension (n=4; 1%). Obstetric complications were recorded for 107 (36%) women and 
included gestational diabetes (n=44; 15%), pregnancy induced hypertensive disorders (n=26; 
9.0%), gestational thrombocytopaenia (n=4; 1%), and gestational hypothyroidism (n=4; 1%).  
Use of prescription and non-prescription medications was extremely common during 
pregnancy, with a total of 276  prescription and 972 non-prescription medications reported by 
a total of 297 (99%) women. A total of 145 women (48%) used at least one prescription 
medication during pregnancy, while 296 women (99%) used at least one non-prescription 
medication. The most commonly used prescription and non-prescription medications included 




those in the alimentary tract and metabolism (n=667), blood and blood forming organs (n=189) 
and nervous system (n=125) ATC categories (Appendix 1). Of all medications that were 
reported, 971 (78%) were initiated during pregnancy and over half of these medications (55%) 
were used on a regular basis.  Of the 277 medications (22%) initiated prior to pregnancy, 207 
(75%) were used intermittently whilst a further 70 (25%) medications were used regularly. 
ADRs and allergies were reported in 115 women (38%), with a total of 153 ADRs and 64 
allergies identified. It was found that 91 women (30%) reported at least one ADR, whilst 
another 45 women (15%) reported at least one allergy.  
Medication discrepancies were prevalent, with a total of 686 (55.0%; 95%CI 52.2–57.8%) non-
prescription and prescription medication discrepancies. A total of 254 (84.7% 95%CI 80.6-
88.8%) women had a least one discrepancy in their PHR, and of these, 177 women (70.0%; 
95%CI 64.4-75.7%) had two or more discrepancies. A total of 87 (29%) women had at least 
one prescription discrepancy recorded in their PHR, with 132 of 276 (48%) prescription 
medications associated with a discrepancy. In contrast, a total of 240 (81%) women were found 
to have at least one non-prescription discrepancy, with 554 of 972 (57%) non-prescription 
medications associated with a discrepancy. The majority of women were more likely to have 
two or more non-prescription discrepancies in their PHR (62%). The difference between the 
proportion of prescription and non-prescription discrepancies was found to be statistically 
significant (P-value <0.001). 
Of the discrepancies that were identified, the majority of prescription medication discrepancies 
were likely to be incomplete (44%) and missing (29%), whereas for non-prescription 
medication discrepancies, 302 (55%) were missing and 166 (30%) were incomplete (Figure 
1).  




The most common prescription medications with discrepancies were medications for 
alimentary tract and metabolism (n=46), which includes medications such as insulin and 
metoclopramide (Appendix 1). The next most common discrepancies were found with 
respiratory medications such as those for asthma (n=18), as well as medications for the nervous 
system including anti-epileptics, anti-psychotics and anti-depressants (n=18). The most 
common non-prescription medications that contained discrepancies involved medications for 
alimentary tract and metabolism (n=283) such as pregnancy multivitamins and vitamin D, as 
well as medications for blood and blood forming organs (n=111) which includes iron 
preparations. 
 
For women reporting 1, 2, 3, or ≥4 medications, a significant trend was observed in relation to 
an increasing proportion of a medication discrepancy being identified (25%, 71%, 90%, and 
97% respectively; p<0.0001).  
Of the women who reported an ADR or allergy, a total of 59 (51%; 95% CI 41.8-60.0%) were 
identified as having a discrepancy, which accounted for 101 discrepancies in total. The majority 
of these discrepancies were associated with ADRs (58; 57%). Of the women who had a 
discrepancy, 65% had one discrepancy and 35% having two or more discrepancies. For both 
ADRs and allergies, the most common discrepancy type was “missing” (66% and 72% 
respectively) (Figure 1).  
Discussion 
These findings demonstrate that discrepancies related to medication use and ADRs are 
common in PHRs, with the potential to contribute towards prescribing errors and patient harm.  




While no previous studies have examined the accuracy of the PHR when it comes to medication 
use and ADRs, the reported prevalence of medication discrepancies is similar to that reported 
in previous studies undertaken within other clinical areas, where medication discrepancies were 
identified in up to 70% of patients at hospital admission or discharge.9-13 
The strongest factor associated with the likelihood of a medication discrepancy appeared to be 
the number of medications reported in the interview. One potential explanation for this is that 
the fact that the amount of space for medications in the PHR is small and therefore does not 
allow enough room for all medications to be recorded, or for medications to be accurately 
recorded with sufficient detail. 
 
Non-prescription medication discrepancies were more common than prescription medication 
discrepancies. This could be explained by the fact that patients under-report their use of non-
prescription medications, with a previous study showing that 53.2% of patients did not report 
non-prescription medication use to their general practitioner.15 Another study suggested that 
women use complementary medicines to avoid taking prescription medications during their 
pregnancy and that many women perceive complementary medication use as natural and 
without risk or the occurrence of side effects.16  
Strengths of this study include the use of a detailed medication history to determine medication 
use during pregnancy. This systematic process of undertaking a detailed medication history 
provides much stronger methodological rigour then relying on alternative methods, such as 
maternal self-reporting in a questionnaire. Highlighting this point is the finding that 99% of 
women reported using at least one medication during pregnancy in our study, whereas in a 
recent Australian study 83.1% of women self-reported use of at least one medication through 
a questionnaire. Limitations are that this study was only conducted at one hospital site, making 




it difficult to evaluate the generalizability of these findings to other hospital settings, especially 
where different PHRs may be in use. Participant recall could be another limitation of this study, 
despite prompting women about medications as part of the detailed medication history, there 
may still be a potential for recall issues. Another potential limitation may include the fact that 
we did not reconcile each woman’s medication history with general practitioners or community 
pharmacies, unless patients were unsure about what they were taking.  
In summary, the PHR appears to be of low accuracy in relation to the recording of medications 
and ADRs, warranting further research to examine the impact of these discrepancies on patient 
care and outcomes. Furthermore, these findings suggest the need for strategies to improve the 
accuracy of information on medication use and ADRs to enhance continuity of care in the 
obstetric setting.  
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Figure 1. Types of Discrepancies Identified 
 
  








Medication ADR or Allergy 
Incomplete Medication recorded in PHR, 
however vital information such as 
dose and frequency are missing 
(e.g. levetiracetam recorded in PHR 
without a dose or frequency)  
ADR or allergy documented in part 
in PHR, but with incomplete details 
(e.g. penicillin allergy recorded 
without any details specifying the 
reaction). 
Incorrect Medication details provided in PHR 
are incorrect with respect to the 
documented dose or frequency, for 
example (e.g. phenytoin dose 
increased during pregnancy but not 
updated in PHR) 
ADR or allergy documented in 
PHR is incorrect when compared to 
that identified during the interview 
(e.g. penicillin reaction recorded as 
patient not experiencing shortness 
of breath when they actually did) 
Missing Medication identified during 
interview but not documented in 
PHR (e.g. patient reported taking 
sertraline with no record of use in 
PHR) 
ADR or allergy identified during 
interview but not documented in 
PHR (e.g. NSAID sensitive asthma 




Medication recorded in PHR, 
however, according to the interview 
this medication was not actually 
used during pregnancy (e.g. PHR 
Not Applicable 




documentation that patient taking 
low-dose aspirin for pre-eclampsia 
prophylaxis, but patient reported 
never actually taking it) 
Abbreviations: ADR, adverse drug reaction; PHR, pregnancy handheld record; NSAID, 








Appendix 1: Medication Discrepancies According to ATC Code and Prescription Type 
 Prescription Medication Discrepancy Non-prescription Medication 
Discrepancy 
 
 Yes No Medication 
Example 
Yes No Medication 
Example 
Total 
 N (%) N (%)  N (%) N (%)   
A - Alimentary Tract and Metabolism  46 (54) 39 (46) Omeprazole 283 (49) 299 (51) Cholecalciferol, 
multivitamin 
667 
B - Blood and Blood Forming Organs  1 (17) 5 (83) Enoxaparin 111 (61) 72 (39) Iron supplement 189 
C - Cardiovascular System  2 (20) 8 (80) Labetalol 22 (88) 3 (12) Omega-3 
triglycerides 
35 
D - Dermatologicals  2 (100) 0 (0) Betamethasone 
cream 
9 (82) 2 (18) Aciclovir 13 
G - Genitourinary System and Sex 
Hormones  
4 (67) 2 (33) Progesterone 
pessaries 
7 (64) 4 (36) Clotrimazole 
pessaries 
17 
H - Systemic Hormonal Preparations 
excluding Sex Hormones and Insulins  
5 (23) 17 (77) Thyroxine 0 0 - 22 
J - Anti-Infectives for Systemic Use 35 (81) 8 (19) Amoxycillin 0 0 - 43 
L - Antineoplastic and 
Immunomodulating Agents  
0 1 (100) Azathioprine 0 0 - 1 
M - Musculoskeletal System  1 (100) 0 Sulphasalazine 1 (50) 1 (50) Ibuprofen 3 
N - Nervous System  18 (50) 18 (50) Sertraline 58 (65) 31 (35) Paracetamol 125 
P - Anti-parasitic Products, Insecticides 
and Repellents 
0 0 - 1 (100) 0 Pyrantel 1 
R - Respiratory System   18 (28) 46 (72) Fluticasone and 
Salmeterol 
15 (94) 1 (6) Loratadine 80 
Other† N/A N/A - 47 (90) 5 (10) Raspberry leaf 
tea 
52 
Total 132 (48) 144 (52)  554 (57) 418 (43)  1248 
N/A: not applicable 
†Indicates medications not covered under the ATC codes  
Author’s Post-Print Version; Copyright – ANZJOG; doi: 10.1111/ajo.12371 
 
 
 
 
